Your browser doesn't support javascript.
loading
Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients.
Zeng, Huilan; Zhang, Deyao; Yang, Zhenyun; Hu, Zili; Yang, Zhoutian; Fu, Yizhen; Hou, Jingyu; Ngai, Siegmund; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Zhou, Zhongguo; Chen, Minshan; Zhang, Yaojun; Pan, Yangxun.
Afiliação
  • Zeng H; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Zhang D; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Yang Z; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Hu Z; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Yang Z; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Fu Y; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Hou J; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Ngai S; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Wang J; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Chen J; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Hu D; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Zhou Z; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Chen M; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Zhang Y; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
  • Pan Y; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong Province, People's Republic of China; Department of Liver Surgery, Sun YatSen University Cancer Center, Guangzhou 510060, Guangdong
Int Immunopharmacol ; 115: 109651, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36638663
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article